Document Detail


Anticancer Activity of Branched-chain Derivatives of Oleic Acid.
MedLine Citation:
PMID:  21965723     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: A number of unsaturated fatty acids and a few saturated branched-chain fatty acids have been reported to exhibit anticancer activity.
MATERIALS AND METHODS: In previously reported research, several novel branched-chain derivatives (methyl, n-butyl, phenyl) of methyl oleate were produced by bromination in the allylic position and subsequent treatment with organocuprate reagents. These compounds and their free acid counterparts were tested in vitro for their antiproliferative activities against two cancer cell lines: MCF-7 (human breast) and HT-29 (human colon). In addition, two sets of isomeric tertiary alcohols obtained as side-products in the synthesis of the branched-chain derivatives were evaluated. Testing was performed at three concentration levels (50, 100, and 200 ppm) in dimethyl sulfoxide (DMSO).
RESULTS: The greatest growth inhibitory activity was exhibited by the branched phenyl derivative of oleic acid, with IC(50) at 48 ppm against both MCF-7 and HT-29. The branched n-butyl derivative of oleic acid also exhibited significant antiproliferative activity, with IC(50) at 82 ppm against MCF-7 and 77 ppm against HT-29.
CONCLUSION: The observed potent anticancer activity of the n-butyl and phenyl derivatives indicates that certain synthetic branched-chain unsaturated fatty acids have potential in the treatment of cancer and further research is warranted.
Authors:
Oliver D Dailey; Xi Wang; Feng Chen; Guohui Huang
Related Documents :
8318653 - Preparation of aflatoxin b1 8,9-epoxide using m-chloroperbenzoic acid.
623753 - Fractionation of aurintricarboxylic acid and effects of its components on nuclear swell...
8191913 - Administration of a branched-chain amino acid preparation during hepatic failure: a stu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  31     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  3165-9     Citation Subset:  IM    
Affiliation:
USDA, ARS, Southern Regional Research Center, 1100 Robert E. Lee Blvd., New Orleans, LA 70124, U.S.A. Oliver.Dailey@ars.usda.gov.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  TGF-{beta} Regulation of Focal Adhesion Proteins and Motility of Premalignant Oral Lesions via Prote...
Next Document:  Enhanced Efficacy of Gemcitabine by Indole-3-carbinol in Pancreatic Cell Lines: The Role of Human Eq...